Tag: Prodigy Diabetes Care

WASHINGTON - Three types of diabetes test strips account for 58% of the Medicare mail-order market share, according to a study released Nov. 25 by the Office of Inspector General (OIG).The OIG examined 1,210 claims from the three-month period of October 2013 through December 2013. This is the third of three reports released in 2014 that the OIG has released to ensure that winning bidders are meeting the 50% market share requirement required by the Medicare Improvements for Patients and Providers...

CHARLOTTE, N.C. - Prodigy Diabetes Care has conducted a regulatory assessment by an independent auditor to examine, review and revise certain procedures and training to ensure compliance with FDA requirements, it told patients, caregivers and partners in a Sept. 4 letter.“Prodigy assures you that this attention to improvement is an ongoing effort to ensure full compliance,” stated CEO Richard Admani in the letter.In a Feb. 22 letter, the FDA warned Prodigy about numerous violations, including...

CHARLOTTE, N.C. - Prodigy Diabetes Care has tripled its volume since January, when CMS announced the payment amounts associated with the national mail-order program for diabetes supplies, says Jennifer Andrews, vice president of marketing and government sales.“We believe, based on all the Medicare claims that we have, that we are now at 40% market share,” she said.Starting July 1, the payment amounts for diabetes supplies dropped to, on average, 72% below the fee schedule. That means,...

CHARLOTTE, N.C. - Prodigy Diabetes Care has formed a partnership with Rx 'n Go, an alternative pharmacy network, to offer fixed price diabetes monitors and test strips, according to a press release. The initiative, which takes effect July 1, 2013, is designed to reduce medical costs on diabetes supplies for self-funded employers. Under the partnership, payers are incentivized to offer their diabetes members access to supplies at no cost. “With all the changes healthcare reform is...

CHARLOTTE, N.C. �- Prodigy Diabetes Care, a distributor of diabetes testing supplies, has acquired substantial ownership of the publicly owned shares of OK Biotech, a manufacturing partner based in Taiwan, according to a press release. For its part, OK Biotech has purchased a minority stake in Prodigy Diabetes. The two companies formed the new relationship to meet the demand of a consolidated customer base for high-volume, lower cost diabetes testing supplies, according to the release. Once the 72%...